^“Regulation of retinoblastoma protein functions by ectopic expression of human cyclins”. Cell70 (6): 993–1006. (September 1992). doi:10.1016/0092-8674(92)90249-c. PMID1388095.
^“CP110, a cell cycle-dependent CDK substrate, regulates centrosome duplication in human cells”. Developmental Cell3 (3): 339–50. (September 2002). doi:10.1016/s1534-5807(02)00258-7. PMID12361598.
^“CDK2-dependent phosphorylation of FOXO1 as an apoptotic response to DNA damage”. Science314 (5797): 294–7. (October 2006). doi:10.1126/science.1130512. PMID17038621.
^“The oncogenic activity of cyclin E is not confined to Cdk2 activation alone but relies on several other, distinct functions of the protein”. The Journal of Biological Chemistry277 (42): 39909–18. (October 2002). doi:10.1074/jbc.M205919200. PMID12149264.
^“Expression and amplification of cyclin genes in human breast cancer”. Oncogene8 (8): 2127–33. (August 1993). PMID8336939.
^“Cyclin E, a potential prognostic marker for breast cancer”. Cancer Research54 (2): 380–5. (January 1994). PMID7903908.
^“Cyclin E and prognosis in patients with breast cancer”. The New England Journal of Medicine347 (20): 1546–7. (November 2002). doi:10.1056/NEJMNEJMp020124. PMID12432040.
^“Expression of cyclin E in human gastric adenomas and adenocarcinomas: correlation with proliferative activity and p53 status”. Journal of Experimental Therapeutics & Oncology1 (2): 88–94. (March 1996). PMID9414392.
^“Concurrent amplification of cyclin E and CDK2 genes in colorectal carcinomas”. International Journal of Cancer62 (1): 25–8. (July 1995). doi:10.1002/ijc.2910620107. PMID7601562.
^“Meta-analysis for cyclin E in lung cancer survival”. Clinica Chimica Acta; International Journal of Clinical Chemistry413 (7–8): 663–8. (April 2012). doi:10.1016/j.cca.2011.12.020. PMID22244930.